| Name | Title | Contact Details |
|---|
CareRev is a marketplace technology that connects hospitals and health systems and local, vetted healthcare professionals on demand. We help our customers build a more flexible and resilient workforce by lowering premium labor costs, automating staffing operations, and building a modern-day float pool powered by technology.
Calypte Biomedical Corporation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Portland, OR. To find more information about Calypte Biomedical Corporation, please visit www.calypte.com
Today, Dynex designs and manufactures a full range of automated workstations, laboratory instruments, and associated consumables that enable scientists and clinicians to make breakthrough discoveries, earlier, more-accurate diagnoses - innovations to
XpresSpa is the industry-leading luxury travel spa business and wholly owned subsidiary of XpresSpa Group Inc. (Nasdaq: XSPA). Serving almost one million air travelers each year at its 57 locations in the United States, Holland and the United Arab Emirates, including stores in 23 airports and 1 off-airport location at Westfield`s World Trade Center in New York City. XpresSpa offers travelers premium spa services, including massages, reflexology, stress and tension release, manicures, pedicures, facials and waxing. Its Xpres nail, massage and hair blow-out services are designed specifically for the busy traveling customer. In stores and online, XpresSpa also sells exclusive luxury travel products and accessories, including travel pillows, blankets, massagers, and personal, hair, nail and bath and body products. XpresSpa has over 750 employees, including talented teams of professionally licensed massage therapists, cosmetologists and nail technicians who are committed to providing exceptional customer experiences.
Cleveland BioLabs, Inc. (NASDAQ: CBLI) is an innovative bio pharmaceutical company developing novel approaches to activate the immune system and address serious medical needs. Our proprietary platform of toll-like immune receptor activators has applications in radiation mitigation, oncology immunotherapy, and vaccines. We combine our proven scientific expertise and our depth of knowledge about our products’ mechanisms of action into a passion for developing drugs to save lives. Our proprietary drug candidates act via unique mechanisms that are designed to kill cancer and protect healthy cells. Our most advanced product candidate is entolimod, which we are developing as a radiation countermeasure and an immunotherapy for oncology and other indications. We have additional pipeline product candidates in various stages of development.